For the Isf, the approach that was followed by the Intesa Sanpaolo Group with the Oo.Ss could be adopted. with the signing of the Protocol for the sustainable development of the Group. It is evidently a question of the so-called "hybrid contract", and, therefore, of the existence between the same subjects 
"of two employment relationships: one subordinate and one self-employed". This is an issue on which it would be useful for the social partners of the chemical-pharmaceutical sector to discuss
On Quotidianosanità the lawyers Lorenzo Maratea and Maurizio Campagna (FPB law firm) reflect on the contractual framework of the ISF, at the same time extending the reflection beyond the field of the qualification of the relationship to embrace some aspects which, in normal cases, are not of labor law, i.e. those relating to the models pursuant to Legislative Decree 231/2001 and more generally to compliance, which, however, have a lot to say about the blurring of the rigid distinction between autonomy and subordination.
To read the article click on the link Daily health of 5 September 2018
…It is clear that the informant is a figure in some ways "paradoxical". Appointed by a subject (the pharmaceutical company) in whose interest it operates, however, it has to perform a crucial function in a relevant perspective far beyond the company's interest which is to expose the characteristics of drugs to doctors and pharmacists assuming an obligation of "truth" with respect to the characteristics of the products. …
